European Commission logo
polski polski
CORDIS - Wyniki badań wspieranych przez UE
CORDIS

Pharmaceutical Open Innovation Test Bed for Enabling Nano-pharmaceutical Innovative Products

Rezultaty

Phoenix Webpage

Phoenix webpage for project and OITB visibility and transparency

Open Call Document

The democases will be chosen after a competitive open call that will be launched by the PhoenixOITB and will be announced and communicated through Phoenix website

LinkedIn, Twitter, ResearchGate accounts created and active

BNN manages social media accounts for increasing visibility disseminating the progress and results

Online Draft and Final Phoenix Service Portfolio including prices and conditions

List of high standard of service to stakeholders as an integrated association of complementary service providers across Europe Draft version will be s on M18 amd teh final version on 48

Foundation of the Phoenix-OITB

PhoenixOITB will be established officially and legally as a nonprofit association

Publikacje

High-Throughput Method for the Simultaneous Determination of Doxorubicin Metabolites in Rat Urine after Treatment with Different Drug Nanoformulations

Autorzy: Lara Zorić; Nikša Drinković; Vedran Micek; Leo Frkanec; Akif Emre Türeli; Nazende Günday-Türeli; Ivana Vinković Vrček; Ruža Frkanec
Opublikowane w: Molecules, Numer 2, 2022, ISSN 1420-3049
Wydawca: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/molecules27041177

Imaging mass spectrometry differentiates the effects of doxorubicin formulations on non-targeted tissues

Autorzy: Željko Debeljak, Ivana Vinković Vrček, Nikša Drinković, Vedran Micek, Emerik Galić, Dunja Gorup, Marija Ćurlin, Dario Mandić, Ana Bandjak, Barbara Pem, Nikolina Kalčec, Krunoslav Ilić, Ivan Pavičić, Suzana Mimica, Nazende Günday-Türeli and Emre Türeli
Opublikowane w: Analyst, 2022, ISSN 1364-5528
Wydawca: Royal Society of Chemistry
DOI: 10.1039/d2an00355d

Hierarchical Quatsome-RGD Nanoarchitectonic Surfaces for Enhanced Integrin-Mediated Cell Adhesion

Autorzy: Marc Martínez-Miguel; Miquel Castellote-Borrell; Mariana Köber; Adriana R. Kyvik; Judit Tomsen-Melero; Guillem Vargas-Nadal; Jose Muñoz; Daniel Pulido; Edgar Cristóbal-Lecina; Solène Passemard; Miriam Royo; Marta Mas-Torrent; Jaume Veciana; Marina I. Giannotti; Judith Guasch; Nora Ventosa; Imma Ratera
Opublikowane w: ACS Applied Materials and Interfaces, Numer 14, 42, 2022, ISSN 1944-8244
Wydawca: American Chemical Society
DOI: 10.1021/acsami.2c10497

Liposomal formulations for treating lysosomal storage disorders

Autorzy: Judit Tomsen-Melero; Josep Merlo-Mas; Aida Carreño; Santi Sala; Alba Córdoba; Jaume Veciana; Elisabet González-Mira; Nora Ventosa
Opublikowane w: Advanced Drug Delivery Reviews, Numer vol 190, 2022, ISSN 1872-8294
Wydawca: Elsevier
DOI: 10.1016/j.addr.2022.114531

DELOS Nanovesicles-Based Hydrogels: An Advanced Formulation for Topical Use

Autorzy: Lídia Ballell-Hosa; Elisabet González-Mira; Hector Santana; Judit Morla-Folch; Marc Moreno-Masip; Yaima Martínez-Prieto; Albert Revuelta; Primiano Pio Di Mauro; Jaume Veciana; Santi Sala; Lidia Ferrer-Tasies; Nora Ventosa
Opublikowane w: Pharmaceutics; Volume 14; Numer 1; Pages: 199, Numer 1, 2022, Strona(/y) MDPI, ISSN 1999-4923
Wydawca: Multidisciplinary Digital Publishing Institute (MDPI)
DOI: 10.3390/pharmaceutics14010199

Stable nanovesicles formed by intrinsically planar bilayers

Autorzy: Mariana Köber, Sílvia Illa-Tuset, Lidia Ferrer-Tasies, Evelyn Moreno-Calvo, Witold I. Tatkiewicz, Natascia Grimaldi, David Piña, Alejandro Pérez Pérez, Vega Lloveras, José Vidal-Gancedo, Donatella Bulone, Imma Ratera, Jan Skov Pedersen, Dganit Danino, Jaume Veciana, Jordi Faraudo, Nora Ventosa
Opublikowane w: Journal of Colloid and Interface Science, Numer Volume 631, Part A, 2023, Strona(/y) Pages 202-211,, ISSN 0021-9797
Wydawca: Academic Press
DOI: 10.1016/j.jcis.2022.10.104

Multiscale imaging of the immune cell therapy biodistribution

Autorzy: de Kruijf, Robbin; Srinivas, Mangala; Simon, James
Opublikowane w: Numer 1, 2023
Wydawca: Advanced Therapies
DOI: 10.5281/zenodo.10658241

PHOENIX-OITB – A single entry point to develop and upgrade innovative nanopharmaceuticals

Autorzy: Scheper, Johanna; Cordoba, Alba; Padrós, Ariadna; Ventosa, Nora; De la Fuente, Jesus M.; Vinković Vrček, Ivana; Bauer, Hannes; Srinivas, Mangala; Fleischer, Sabine; Holzer, Robert; Serchi, Tommaso; Günday-Türeli, Nazende
Opublikowane w: Numer 2, 2023
Wydawca: BioNanoMed 2023
DOI: 10.5281/zenodo.7851928

Wyszukiwanie danych OpenAIRE...

Podczas wyszukiwania danych OpenAIRE wystąpił błąd

Brak wyników